Publications by authors named "J M Ramos-Goni"
Objectives: US stakeholders advised including adolescents in the valuation study for the EQ-5D-Y-3L, a step toward greater acknowledgment of children in informing societal values. This study aimed to assess the relative contribution of adolescent and adult preferences to a model when combined.
Methods: Discrete choice experiment data were collected from an online sample of 1529 adults and 714 adolescents (ages 11-17).
Article Synopsis
- Vedolizumab is a specialized biologic treatment intended for adults with moderate to severe ulcerative colitis (UC) and Crohn's disease (CD) in Canada.
- The study aimed to analyze the cost-effectiveness of two treatment sequences: starting with vedolizumab versus starting with anti-TNFα biologics for patients new to treatment.
- Results indicated that using vedolizumab first is more effective and less expensive for UC patients, saving over $7,000, while also providing a slight increase in quality-adjusted life-years (QALYs); results for CD showed a smaller QALY improvement.